Pharma News

LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA’s consumer health unit, sources told Reuters, and is preparing an indicative offer for the...

At the beginning of 2017, expectations were pretty high that the pharma and biotech sector would finally see lots of mergers and acquisitions (M&As).

Despite being late to market, the collaborators hope a new indication could help boost its prospects.

Needles are usually seen as a necessary evil, but maybe they don't have to be.

Australia’s University of Wollongong (UOW) is quickly becoming a pioneer in 3D bioprinting technologies.

(New York) – Chinese authorities in Xinjiang are collecting DNA samples, fingerprints, iris scans, and blood types of all residents in the region between the age of 12 and 65, Human Rights W...

Amneal Biosciences is launching its generic of Kenalog-40 (triamcinolone acetonide injectable suspension, 40 mg/ml), with the Food and Drug Administration approved Tuesday.

First up, Daiichi Sankyo and Puma Biotechnology (Nasdaq.

UK-based biopharma firm GW Pharmaceuticals (Nasdaq.

The USA-based Cancer Research Institute (CRI) last week published a report that provides a first-of-its-kind independent analysis of the global immuno-oncology (I-O) landscape, from ag...

The Food and Drug Administration (FDA) approved use of Nucala (mepolizumab) for use in treating adults with eosinophilic granulomatosis with polyangiitis (EGPA), previously kno...

A novel type of treatment for major depressive disorder (MDD) achieved the main goal of a phase 2 trial, reducing symptoms during a 2-week treatment period.